Joseph Leventhal
Overview
Explore the profile of Joseph Leventhal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gordon E, Gusmano M, Gacki-Smith J, Brooks H, Matthews M, Manning D, et al.
Xenotransplantation
. 2025 Feb;
32(1):e70016.
PMID: 39995236
Background: Transplant programs preparing to initiate first-in-human pig kidney xenotransplant clinical trials must be especially careful when obtaining participants' informed consent. Little is known about the kind of information patients...
2.
Gordon E, Maschke K, Gacki-Smith J, Brooks H, Matthews M, Traboulsi K, et al.
Xenotransplantation
. 2025 Feb;
32(1):e70013.
PMID: 39912498
First-in-human pig xenotransplant clinical trials may soon begin, which raises ethical concerns about patients' decision-making to participate in such trials. We assessed kidney transplant candidates' attitudes and hypothetical decision-making about...
3.
Stark H, Ho Q, Cross A, Alessandrini A, Bertaina A, Brennan D, et al.
Transplantation
. 2025 Jan;
PMID: 39800883
No abstract available.
4.
Nadig S, Leventhal J, Gallon L, Atkinson C
Front Transplant
. 2024 Jul;
3:1371701.
PMID: 38993759
No abstract available.
5.
Sun J, Ince M, Abraham C, Barrett T, Brenner L, Cong Y, et al.
Gut Microbes
. 2023 Oct;
15(2):2267180.
PMID: 37842912
The present report summarizes the United States Department of Veterans Affairs (VA) field-based meeting titled "Modulating microbiome-immune axis in the deployment-related chronic diseases of Veterans." Our Veteran patient population experiences...
6.
Tawhari I, Hallak P, Bin S, Yamani F, Safar-Boueri M, Irshad A, et al.
Front Immunol
. 2023 Jan;
13:1096881.
PMID: 36601111
Background: Belatacept (Bela) was developed to reduce nephrotoxicity and cardiovascular risk that are associated with the chronic use of Calcineurin inhibitors (CNIs) in kidney transplant recipients. The use of Bela...
7.
Schneiderman J, Qiu L, Yeap X, Kang X, Zheng F, Ye J, et al.
Sci Rep
. 2022 May;
12(1):7298.
PMID: 35508582
Recipients of solid organ transplantation (SOT) rely on life-long immunosuppression (IS), which is associated with significant side effects. Extracorporeal photochemotherapy (ECP) is a safe, existing cellular therapy used to treat...
8.
Kawai T, Leventhal J, Wood K, Strober S
Am J Transplant
. 2018 Aug;
19(2):324-330.
PMID: 30133954
The Third International Workshop on Clinical Tolerance was held in Stanford, California, September 8-9, 2017. This is a summary of Workshop presentations of clinical trials designed to withdraw or minimize...
9.
Chhabra A, Leventhal J, Merchak A, Ildstad S
Transplantation
. 2017 Jun;
101(11):2682-2690.
PMID: 28574903
Renal transplantation has become the preferred treatment for end stage kidney failure. Although short-term graft survival has significantly improved as advances in immunosuppression have occurred, long-term patient and graft survival...
10.
Xie Y, Wu Y, Xin K, Wang J, Xu H, Ildstad S, et al.
Transplantation
. 2017 Feb;
101(5):1056-1066.
PMID: 28187014
Background: Nonmyeloablative conditioning followed by donor bone marrow infusion (BMI) to induce tolerance has not been robustly tested in liver transplantation (LT) and may be unsafe at the time of...